An international clinical trial that studied wearable cardioverter defibrillators (WCDs) found that the devices did not significantly reduce sudden cardiac death—the primary goal of the device—among patients assigned ...
Sep 26, 2018
0
33
A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators (ICDs) found that the drug ranolazine (commonly used to treat chest pain; brand name Ranexa) was safe but didn't significantly decrease ...
Aug 28, 2018
0
5
(HealthDay)—Among patients with coronary heart disease without severe systolic dysfunction, sudden and/or arrhythmic deaths (SAD) account for a considerable proportion of deaths, according to a study published online May ...
May 4, 2018
0
4
(HealthDay)—People who have implanted devices to keep their hearts running smoothly can safely drive an electric car if they wish to do so, new research confirms.
Apr 24, 2018
0
9
For J.R. Bourne, a day at the beach rekindles good and bad memories.
Apr 12, 2018
0
2
In 2012, Olympic gold medalist swimmer Dana Vollmer set a world record even as a genetic condition threatened to stop her heart at any moment. She has long-QT syndrome, one of several inherited heart diseases that can send ...
Feb 27, 2018
0
1
In a study of nearly 6,000 community-based patients with chronic kidney disease and heart failure, the use of implantable cardioverter defibrillators was associated with a significantly increased risk of subsequent hospitalization.
Feb 5, 2018
0
1
In evaluating the quality of care given to those hospitalized with heart failure, adherence to clinical guidelines may be a better measure of quality than the number of heart failure patients a hospital admits, according ...
Jan 29, 2018
0
4
Four in ten cardiomyopathies - a major cause of sudden cardiac death and heart failure in young people - are genetic, according to a European Society of Cardiology (ESC) study published today in European Heart Journal.1 Family ...
Jan 24, 2018
0
2
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other ...
Sep 7, 2017
0
0
